Featured
-
-
Article
| Open Access
Population pharmacokinetics of lenalidomide in Chinese patients with influence of genetic polymorphisms of ABCB1
- Xiaoxiao Liang
- , Haiyan Shi
- & Xin Huang
-
Article
| Open Access
CD36 relative mean fluorescence intensity of CD105+ nucleated erythroid cells can be used to differentiate myelodysplastic syndrome from megaloblastic anemia
- Yan Lu
- , Xuya Chen
- & Longyi Zhang
-
Article
| Open Access
Prognostic prediction of novel risk scores (AML-DRG and AML-HCT-CR) in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation
- Weijie Cao
- , Xiaoning Li
- & Jifeng Yu
-
Article
| Open Access
Real world data on the prognostic significance of monocytopenia in myelodysplastic syndrome
- Panagiotis T. Diamantopoulos
- , Emmanouil Charakopoulos
- & Athanasios Galanopoulos
-
Article
| Open Access
Exploring the mechanistic link between SF3B1 mutation and ring sideroblast formation in myelodysplastic syndrome
- Tetsuro Ochi
- , Tohru Fujiwara
- & Hideo Harigae
-
Article
| Open Access
Incidence of myeloid neoplasms in Spain (2002–2013): a population-based study of the Spanish network of cancer registries
- Marta Solans
- , Arantza Sanvisens
- & Rafael Marcos-Gragera
-
Article
| Open Access
Decreased PGC1β expression results in disrupted human erythroid differentiation, impaired hemoglobinization and cell cycle exit
- Taha Sen
- , Jun Chen
- & Sofie Singbrant
-
Article
| Open Access
Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression
- Marie-Theresa Weickert
- , Judith S. Hecker
- & Katharina S. Götze
-
Article
| Open Access
Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia
- Mattias Hofmans
- , Tim Lammens
- & Barbara De Moerloose
-
Article
| Open Access
Molecular-Based Score inspired on metabolic signature improves prognostic stratification for myelodysplastic syndrome
- Juan L. Coelho-Silva
- , Douglas R. A. Silveira
- & Fabiola Traina
-
Article
| Open Access
Assessment of dysplasia in bone marrow smear with convolutional neural network
- Jinichi Mori
- , Shizuo Kaji
- & Akira Matsuda
-
Article
| Open Access
Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: results from the multicenter FISM BIOFER study
- Daniela Cilloni
- , Silvia Ravera
- & Francesco Frassoni
-
Article
| Open Access
A genetic development route analysis on MDS subset carrying initial epigenetic gene mutations
- Xiao Li
- , Feng Xu
- & Dong Wu
-
Article
| Open Access
Comparison between 5-day decitabine and 7-day azacitidine for lower-risk myelodysplastic syndromes with poor prognostic features: a retrospective multicentre cohort study
- Byung-Hyun Lee
- , Ka-Won Kang
- & Yong Park
-
Article
| Open Access
A novel automated image analysis system using deep convolutional neural networks can assist to differentiate MDS and AA
- Konobu Kimura
- , Yoko Tabe
- & Akimichi Ohsaka
-
Article
| Open Access
A New Approach for the Diagnosis of Myelodysplastic Syndrome Subtypes Based on Protein Interaction Analysis
- Leona Chrastinová
- , Ondřej Pastva
- & Jan E. Dyr
-
Article
| Open Access
Discovery of selective activators of PRC2 mutant EED-I363M
- Junghyun L. Suh
- , Kimberly D. Barnash
- & Stephen V. Frye
-
Article
| Open Access
Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability
- Fabio Giuseppe Liberante
- , Katrina Lappin
- & Kenneth Ian Mills
-
Article
| Open Access
ASXL1 and SETBP1 mutations promote leukaemogenesis by repressing TGFβ pathway genes through histone deacetylation
- Makoto Saika
- , Daichi Inoue
- & Susumu Goyama
-
Article
| Open Access
Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML
- Antònia Banús-Mulet
- , Amaia Etxabe
- & Ruth M. Risueño
-
Article
| Open Access
NPM-hMLF1 fusion protein suppresses defects of a Drosophila FTLD model expressing the human FUS gene
- Itaru Yamamoto
- , Yumiko Azuma
- & Masamitsu Yamaguchi
-
Article
| Open Access
PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation
- Chao Hu
- , Mengxia Yu
- & Hongyan Tong
-
Article
| Open Access
Ribosomal protein L23 negatively regulates cellular apoptosis via the RPL23/Miz-1/c-Myc circuit in higher-risk myelodysplastic syndrome
- Yuekun Qi
- , Xiao Li
- & Lingyun Wu
-
Article
| Open Access
Downregulation of MMP1 in MDS-derived mesenchymal stromal cells reduces the capacity to restrict MDS cell proliferation
- Sida Zhao
- , Youshan Zhao
- & Chunkang Chang
-
Article
| Open Access
Exploration of the role of gene mutations in myelodysplastic syndromes through a sequencing design involving a small number of target genes
- Feng Xu
- , Ling-Yun Wu
- & Xiao Li
-
Article
| Open Access
De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes
- Matheus Rodrigues Lopes
- , João Kleber Novais Pereira
- & Patricia Favaro
-
Article
| Open Access
Identification of microRNA-regulated pathways using an integration of microRNA-mRNA microarray and bioinformatics analysis in CD34+ cells of myelodysplastic syndromes
- Feng Xu
- , Yang Zhu
- & Xiao Li
-
Article
| Open Access
ASXL1 plays an important role in erythropoiesis
- Hui Shi
- , Shohei Yamamoto
- & Feng-Chun Yang
-
Article
| Open Access
H2AX deficiency is associated with erythroid dysplasia and compromised haematopoietic stem cell function
- Baobing Zhao
- , Timothy L. Tan
- & Peng Ji
-
Article
| Open Access
Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome
- Feng Xu
- , Qi He
- & Liyu Zhou
-
Article
| Open Access
Specific Plasma Autoantibody Reactivity in Myelodysplastic Syndromes
- George I. Mias
- , Rui Chen
- & Peter L. Greenberg
Comparative analysis of feature-based ML and CNN for binucleated erythroblast quantification in myelodysplastic syndrome patients using imaging flow cytometry data